Avict Global Holdings Limited - Net Worth and Insider Trading
Avict Global Holdings Limited Net Worth
The estimated net worth of Avict Global Holdings Limited is at least $47 Million dollars as of 2024-09-28. Avict Global Holdings Limited is the 2101 Beneficial owner of Shenzhen Hepalink Pharmaceutical Group Co Ltd and owns about 12,629,500 shares of Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) stock worth over $47 Million. Details can be seen in Avict Global Holdings Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Avict Global Holdings Limited has not made any transactions after 2020-07-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Avict Global Holdings Limited
Avict Global Holdings Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Avict Global Holdings Limited owns 1 companies in total, including Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) .
Click here to see the complete history of Avict Global Holdings Limited’s form 4 insider trades.
Insider Ownership Summary of Avict Global Holdings Limited
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:09989 | Shenzhen Hepalink Pharmaceutical Group Co Ltd | 2020-07-08 | 2101 Beneficial owner |
Avict Global Holdings Limited Latest Holdings Summary
Avict Global Holdings Limited currently owns a total of 1 stock. Avict Global Holdings Limited owns 12,629,500 shares of Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) as of July 8, 2020, with a value of $47 Million.
Latest Holdings of Avict Global Holdings Limited
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:09989 | Shenzhen Hepalink Pharmaceutical Group Co Ltd | 2020-07-08 | 12,629,500 | 3.74 | 47,234,330 |
Holding Weightings of Avict Global Holdings Limited
Avict Global Holdings Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Avict Global Holdings Limited has made a total of 1 transactions in Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Shenzhen Hepalink Pharmaceutical Group Co Ltd is the sale of 12,629,500 shares on July 8, 2020, which brought Avict Global Holdings Limited around $0.
Insider Trading History of Avict Global Holdings Limited
- 1
Avict Global Holdings Limited Trading Performance
Avict Global Holdings Limited Ownership Network
Avict Global Holdings Limited Owned Company Details
What does Shenzhen Hepalink Pharmaceutical Group Co Ltd do?
Who are the key executives at Shenzhen Hepalink Pharmaceutical Group Co Ltd?
Avict Global Holdings Limited is the 2101 Beneficial owner of Shenzhen Hepalink Pharmaceutical Group Co Ltd. Other key executives at Shenzhen Hepalink Pharmaceutical Group Co Ltd include 2101 Beneficial owner hong ze jun , 2102 Investment manager Orbimed Capital Llc , and 2105 Underwriter Morgan Stanley & Co. International Plc .
Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) Insider Trades Summary
Over the past 18 months, Avict Global Holdings Limited made no insider transaction in Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989). Other recent insider transactions involving Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) include a net purchase of 670,000 shares made by hong ze jun ,
In summary, during the past 3 months, insiders sold 0 shares of Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989) were sold and 670,000 shares were bought by its insiders, resulting in a net purchase of 670,000 shares.
Shenzhen Hepalink Pharmaceutical Group Co Ltd (HKSE:09989)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shenzhen Hepalink Pharmaceutical Group Co Ltd Insider Transactions
Avict Global Holdings Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Avict Global Holdings Limited. Currently GuruFocus does not have mailing address information for Avict Global Holdings Limited.